+28.2%
MRNA vs CAPR
+36.9%
-8.7%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CAPR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -4.6% | +1.3% | -3.2% |
| 7D | -10.1% | -12.6% | +2.6% | -9.7% |
| 30D | +126.7% | +124.4% | +2.3% | +122.3% |
| 3M | +184.1% | -66.8% | +250.9% | +187.0% |
| 6M | +143.3% | -71.8% | +215.1% | +146.5% |
| YTD | +359.9% | -70.1% | +429.9% | +364.8% |
| 1Y | +454.2% | +33.3% | +420.9% | +413.7% |
| All | +28.2% | +36.9% | -8.7% | +3.0% |
Cumulative growth
Daily Returns
Daily percentage return beside CAPR.
Daily Out/Under-Performance
Portfolio return minus CAPR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CAPR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CAPR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling